Neogen Corporation (NEOG) |
|
20.04 0.16 (0.8%)
|
01-27 16:00 |
|
Open: |
19.72 |
Pre. Close: |
19.88 |
|
High:
|
20.08 |
Low:
|
19.6 |
|
Volume:
|
1,492,098 |
Market Cap:
|
4,332(M) |
|
|
|
Technical analysis |
as of: 2023-01-27 4:46:32 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 23.59 One year: 27.55 |
| Support: |
Support1: 16.66 Support2: 14.47 |
| Resistance: |
Resistance1: 20.2 Resistance2: 23.59 |
| Pivot: |
18.66 |
| Moving Average: |
MA(5): 19.93 MA(20): 17.87
MA(100): 15.26 MA(250): 22.55  |
| MACD: |
MACD(12,26): 1.2 Signal(9): 1 |
| Stochastic oscillator: |
%K(14,3): 95.8 %D(3): 96.1 |
| RSI: |
RSI(14): 81.3 |
| 52-week: |
High: 36.9 Low: 10.48 |
| Average Vol(K): |
3-Month: 3,334 (K) 10-Days: 2,307 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ NEOG ] has closed below upper band by 21.5%. Bollinger Bands are 24% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
20.1 - 20.2 |
20.2 - 20.28 |
|
Low:
|
19.37 - 19.48 |
19.48 - 19.58 |
|
Close:
|
19.87 - 20.05 |
20.05 - 20.2 |
|
Company Description |
|
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers and processors; grain producers and processors; producers of cookies, crackers, candy, ice cream, and other processed foods; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segment's products are used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan. |
Headline News |
Thu, 19 Jan 2023
Should You Buy Neogen Corporation (NEOG) Stock After it Has Risen 8.41% in a Week? - InvestorsObserver
Tue, 10 Jan 2023
StockNews.com Lowers Neogen (NASDAQ:NEOG) to Sell - MarketBeat
Tue, 10 Jan 2023
Neogen Corporation (NASDAQ:NEOG) Q2 2023 Earnings Call Transcript - Yahoo Finance
Fri, 06 Jan 2023
Should You Buy Neogen Corporation (NEOG) Stock on Friday? - InvestorsObserver
Fri, 06 Jan 2023
Neogen (NEOG) Q2 Earnings Top Estimates, Gross Margin Up - Zacks Investment Research
Thu, 05 Jan 2023
Health Care Sector Update for 01/05/2023: WBA, NEOG, ANGO ... - Nasdaq
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. |
216 (M) |
| Shares Float |
108 (M) |
|
% Held by Insiders
|
0.1 (%) |
|
% Held by Institutions
|
93.5 (%) |
|
Shares Short
|
9,710 (K) |
|
Shares Short P.Month
|
14,370 (K) |
Stock Financials |
|
EPS
|
0.34 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
8.19 |
|
Profit Margin (%)
|
6.8 |
|
Operating Margin (%)
|
12.8 |
|
Return on Assets (ttm)
|
4.4 |
|
Return on Equity (ttm)
|
4.1 |
|
Qtrly Rev. Growth
|
3.2 |
|
Gross Profit (p.s.)
|
1.12 |
|
Sales Per Share
|
2.45 |
|
EBITDA (p.s.)
|
0.42 |
|
Qtrly Earnings Growth
|
-69.6 |
|
Operating Cash Flow
|
31 (M) |
|
Levered Free Cash Flow
|
2 (M) |
Stock Valuations |
|
PE Ratio
|
58.94 |
|
PEG Ratio
|
-14.7 |
|
Price to Book value
|
2.44 |
|
Price to Sales
|
8.15 |
|
Price to Cash Flow
|
141.16 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
